Offering SPR-BLI Services - Proteins provided for free!
Get your basement membrane extract free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
>
Zytokin-Nachweis-ELISA-Kits
Schnell und einfach zu bedienen:2-stündiger Test, der nur 7 Schritte erfordert.
Beständigkeit: Kalibriert nach NIBSC/WHO-Standards, um die Konsistenz von Charge zu Charge zu gewährleisten.
Strenge Qualitätskontrolle: Hohe Empfindlichkeit, Spezifität, Genauigkeit, Linearität und Inter-/Intrapräzision.
Validierte Methode: Umfassende Validierung mit vorhandener Verfahrensbeschreibung und professionellem technischen Support rund um die Uhr.
Minimale Matrix-Interferenz: Geringe Matrixinterferenz in Zellkulturüberständen und Serum nachgewiesen.
Cat. No. | Product Description |
---|
RUO | PRO | ||
---|---|---|---|
Erkennungszeit | 2-3h | 2h | |
Proben- Typ | Cell Culture Supernates, Serum , Plasma | Cell Culture Supernates, Serum , Plasma | |
Qualitätsmanagement-System | ISO13485 | ||
Anleitung zur Validierung | ICH M10 | ||
Experiment zur Validierung | Hakeneffekt | √ | √ |
Matrix-Effekt | Bilirubin, Hemoglobin, Triglyceride | ||
Gerinnungshemmende Wirkung | EDTA, Heparin, Sodium citrate | ||
Einfluss der Lagerungsbedingungen der Proben | 3 Freeze–thaw Cycles | ||
Spezifität | IL-2, IL-4, IL-6, IL-7, IL-10, IL-15, IL-21, IL-1β, TNF-alpha, GM-CSF | IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 p70, IL-13, IL-15, IL-17, GM-CSF, TNF-alpha, IFN-gamma, etc. |
The sensitivity of ClinMax™ Human Interferon-γ (IFN-γ) ELISA Kit (Cat. No. CRS-A017) is 5.309 pg/Ml.
ClinMax™ Human Interferon-γ (IFN-γ) ELISA Kit (Cat. No. CRS-A017) was verified to have an intra/inter-precision of less than 10%.
The sensitivity of ClinMax™ Human IFN-γ ELISA Kit, PRO (Cat. No. CEA-C006) is 3.25 pg/mL.
ClinMax™ Human IFN-γ ELISA Kit, PRO (Cat. No. CEA-C006) was verified to have an intra/inter-precision of less than 10%.
Diseases that are commonly present during sample collection such as jaundice (elevated bilirubin), hemolysis (elevated hemoglobin), and lipemia (elevated triglyceride) were simulated. Bilirubin, hemoglobin, and triglycerides were individually spiked into the sample matrix at a concentration of 20 mg/dL, 3500 g/dL, 2.0 g/L, respectively to evaluate matrix effect on our (XXX) kits.
Anticoagulant effect was tested by spiking the sample with either heparin, EDTA, or sodium citrate at a concentration of 40U/mL, 4mg/mL, and 40mg/mL, respectively.
This web search service is supported by Google Inc.